Trial Profile
A trial to determine optimal Prostate-specific antigen cut-off for PSMA PET/CT scan at biochemical recurrence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 30 Jun 2016 New trial record